Mackay Shields LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-89,508
| Closed | -$10.5M | – | 404 |
|
|
2022
Q1 | $10.5M | Sell |
89,508
-3,529
| -4% | -$415K | 0.09% | 215 |
|
|
2021
Q4 | $12.1M | Sell |
93,037
-1,822
| -2% | -$236K | 0.1% | 213 |
|
|
2021
Q3 | $10.7M | Sell |
94,859
-2,750
| -3% | -$311K | 0.1% | 206 |
|
|
2021
Q2 | $10.1M | Sell |
97,609
-5,803
| -6% | -$601K | 0.1% | 214 |
|
|
2021
Q1 | $8.65M | Sell |
103,412
-675
| -0.6% | -$56.5K | 0.06% | 315 |
|
|
2020
Q4 | $9.5M | Sell |
104,087
-8,377
| -7% | -$764K | 0.07% | 318 |
|
|
2020
Q3 | $8.98M | Buy |
112,464
+3,327
| +3% | +$266K | 0.06% | 330 |
|
|
2020
Q2 | $7.54M | Buy |
109,137
+8,853
| +9% | +$612K | 0.06% | 343 |
|
|
2020
Q1 | $6.31M | Buy |
100,284
+720
| +0.7% | +$45.3K | 0.06% | 341 |
|
|
2019
Q4 | $7.74M | Sell |
99,564
-30,075
| -23% | -$2.34M | 0.05% | 379 |
|
|
2019
Q3 | $9.5M | Buy |
129,639
+21,948
| +20% | +$1.61M | 0.06% | 348 |
|
|
2019
Q2 | $6.63M | Sell |
107,691
-33,348
| -24% | -$2.05M | 0.05% | 437 |
|
|
2019
Q1 | $9M | Sell |
141,039
-18,021
| -11% | -$1.15M | 0.07% | 348 |
|
|
2018
Q4 | $8.12M | Buy |
159,060
+58,872
| +59% | +$3.01M | 0.07% | 356 |
|
|
2018
Q3 | $5.81M | Sell |
100,188
-2,154
| -2% | -$125K | 0.04% | 422 |
|
|
2018
Q2 | $4.97M | Sell |
102,342
-4,524
| -4% | -$220K | 0.03% | 478 |
|
|
2018
Q1 | $4.97M | Buy |
+106,866
| New | +$4.97M | 0.03% | 504 |
|